Senores Pharma to Incorporate Subsidiary in Canada

Senores Pharmaceuticals Limited's Board of Directors has approved the proposed incorporation of a wholly-owned subsidiary in Canada to support international business objectives. The board also approved the appointment of Mrs. Shilpa Sharma as Company Secretary and Compliance Officer, and Mr. Viranchi Arvindbhai Shah as Non-Executive Additional Director (Independent Director). Additionally, the company approved the Senores Pharmaceuticals Employee Stock Option Scheme 2026 (ESOS 2026), subject to shareholder and regulatory approvals. Key managerial personnel were also authorized to determine materiality of events and make disclosures.